Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ayodeji Adegunsoye

Showing results (1-10 of 162) with videos related to

Pageof 17
Sort By:
Thorax|November 1, 2019
<i>MUC5B</i> promoter variant: genomic fingerprint for early identification of undiagnosed pulmonary fibrosisAyodeji Adegunsoye
Annals of the American Thoracic Society|March 2, 2019
Diagnostic Delay in Idiopathic Pulmonary Fibrosis: Where the Rubber Meets the RoadAyodeji Adegunsoye
The Lancet. Respiratory Medicine|June 1, 2023
Interstitial lung disease: a decade of progress and hopeAyodeji Adegunsoye
Chest|August 9, 2021
The Progression to Interstitial Lung Disease: Vicarious Facts About Visceral FatKavitha Selvan, Ayodeji Adegunsoye
Pulmonary Medicine|August 1, 2012
Etiopathogenetic mechanisms of pulmonary hypertension in sleep-related breathing disordersAyodeji Adegunsoye, Siva Ramachandran
Immunology and Allergy Clinics of North America|April 13, 2023
Idiopathic Pulmonary Fibrosis and Progressive Pulmonary FibrosisRachel Strykowski, Ayodeji Adegunsoye
Ebiomedicine|May 9, 2021
Molecular pathways in idiopathic pulmonary fibrosis pathogenesis: Transcending barriers to optimally targeted pharmacotherapiesRachel Strykowski, Ayodeji Adegunsoye
Mediators of Inflammation|May 7, 2015
Inflammatory response mechanisms exacerbating hypoxemia in coexistent pulmonary fibrosis and sleep apneaAyodeji Adegunsoye, Jay Balachandran
Chest|August 14, 2016
Therapeutic Approach to Adult Fibrotic Lung DiseasesAyodeji Adegunsoye, Mary E Strek
Annals of the American Thoracic Society|April 1, 2022
Inhaled Nitric Oxide for Fibrotic Interstitial Lung Disease: A Step ForwardYet H Khor, Ayodeji Adegunsoye
Pageof 17

Showing results (1-10 of 162) with videos related to

Sort By:
Pageof 17
Thorax|November 1, 2019
<i>MUC5B</i> promoter variant: genomic fingerprint for early identification of undiagnosed pulmonary fibrosisAyodeji Adegunsoye
Annals of the American Thoracic Society|March 2, 2019
Diagnostic Delay in Idiopathic Pulmonary Fibrosis: Where the Rubber Meets the RoadAyodeji Adegunsoye
The Lancet. Respiratory Medicine|June 1, 2023
Interstitial lung disease: a decade of progress and hopeAyodeji Adegunsoye
Chest|August 9, 2021
The Progression to Interstitial Lung Disease: Vicarious Facts About Visceral FatKavitha Selvan, Ayodeji Adegunsoye
Pulmonary Medicine|August 1, 2012
Etiopathogenetic mechanisms of pulmonary hypertension in sleep-related breathing disordersAyodeji Adegunsoye, Siva Ramachandran
Immunology and Allergy Clinics of North America|April 13, 2023
Idiopathic Pulmonary Fibrosis and Progressive Pulmonary FibrosisRachel Strykowski, Ayodeji Adegunsoye
Ebiomedicine|May 9, 2021
Molecular pathways in idiopathic pulmonary fibrosis pathogenesis: Transcending barriers to optimally targeted pharmacotherapiesRachel Strykowski, Ayodeji Adegunsoye
Mediators of Inflammation|May 7, 2015
Inflammatory response mechanisms exacerbating hypoxemia in coexistent pulmonary fibrosis and sleep apneaAyodeji Adegunsoye, Jay Balachandran
Chest|August 14, 2016
Therapeutic Approach to Adult Fibrotic Lung DiseasesAyodeji Adegunsoye, Mary E Strek
Annals of the American Thoracic Society|April 1, 2022
Inhaled Nitric Oxide for Fibrotic Interstitial Lung Disease: A Step ForwardYet H Khor, Ayodeji Adegunsoye
Pageof 17